These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30083052)

  • 1. Multiscale Tumor Modeling With Drug Pharmacokinetic and Pharmacodynamic Profile Using Stochastic Hybrid System.
    Oduola WO; Li X
    Cancer Inform; 2018; 17():1176935118790262. PubMed ID: 30083052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Multiscale Modeling with Drug Effects for Cancer Treatment.
    Li XL; Oduola WO; Qian L; Dougherty ER
    Cancer Inform; 2015; 14(Suppl 5):21-31. PubMed ID: 26792977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid multiscale modeling and prediction of cancer cell behavior.
    Zangooei MH; Habibi J
    PLoS One; 2017; 12(8):e0183810. PubMed ID: 28846712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fully coupled space-time multiscale modeling framework for predicting tumor growth.
    Rahman MM; Feng Y; Yankeelov TE; Oden JT
    Comput Methods Appl Mech Eng; 2017 Jun; 320():261-286. PubMed ID: 29158608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A HYBRID THREE-SCALE MODEL OF TUMOR GROWTH.
    Rocha HL; Almeida RC; Lima EABF; Resende ACM; Oden JT; Yankeelov TE
    Math Models Methods Appl Sci; 2018 Jan; 28(1):61-93. PubMed ID: 29353950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoGNaC: A Chaste Plugin for the Multiscale Simulation of Gene Regulatory Networks Driving the Spatial Dynamics of Tissues and Cancer.
    Rubinacci S; Graudenzi A; Caravagna G; Mauri G; Osborne J; Pitt-Francis J; Antoniotti M
    Cancer Inform; 2015; 14(Suppl 4):53-65. PubMed ID: 26380549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Law of Large Numbers in the Supremum Norm for a Multiscale Stochastic Spatial Gene Network.
    Debussche A; Nguepedja Nankep MJ
    Int J Biostat; 2019 May; 15(2):. PubMed ID: 31095509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model.
    Roy M; Finley SD
    PLoS Comput Biol; 2019 Jun; 15(6):e1007053. PubMed ID: 31185009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin.
    Betts AM; Haddish-Berhane N; Tolsma J; Jasper P; King LE; Sun Y; Chakrapani S; Shor B; Boni J; Johnson TR
    AAPS J; 2016 Sep; 18(5):1101-1116. PubMed ID: 27198897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
    Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
    AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges.
    Zou H; Banerjee P; Leung SSY; Yan X
    Front Pharmacol; 2020; 11():997. PubMed ID: 32719604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.
    Singh AP; Shin YG; Shah DK
    Pharm Res; 2015 Nov; 32(11):3508-25. PubMed ID: 25666843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiscale modeling of mucosal immune responses.
    Mei Y; Abedi V; Carbo A; Zhang X; Lu P; Philipson C; Hontecillas R; Hoops S; Liles N; Bassaganya-Riera J
    BMC Bioinformatics; 2015; 16 Suppl 12(Suppl 12):S2. PubMed ID: 26329787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer systems biology and modeling: microscopic scale and multiscale approaches.
    Masoudi-Nejad A; Bidkhori G; Hosseini Ashtiani S; Najafi A; Bozorgmehr JH; Wang E
    Semin Cancer Biol; 2015 Feb; 30():60-9. PubMed ID: 24657638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical modeling and computational prediction of cancer drug resistance.
    Sun X; Hu B
    Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiscale modeling reveals angiogenesis-induced drug resistance in brain tumors and predicts a synergistic drug combination targeting EGFR and VEGFR pathways.
    Liang W; Zheng Y; Zhang J; Sun X
    BMC Bioinformatics; 2019 May; 20(Suppl 7):203. PubMed ID: 31074391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Flow Modeling by Hybrid Automata Alternating Continuous Reaction and Discrete Transit for Pharmacokinetics.
    Koyama S
    Drug Metab Dispos; 2021 Jul; 49(7):521-529. PubMed ID: 33941544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition.
    Alemani D; Pappalardo F; Pennisi M; Motta S; Brusic V
    J Immunol Methods; 2012 Feb; 376(1-2):55-68. PubMed ID: 22154892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.
    Toutain PL
    AAPS PharmSci; 2002; 4(4):E38. PubMed ID: 12646010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.